Table of Contents
Chapter 1. Market Dynamics
1.1. Ongoing Research Focusing On Non-Contrast (Diffusion) Breast MRI
1.2. Adoption Of Abbreviated MRI For Screening Women With Dense Breasts
1.3. Positive Trial Results For Novel Contrast Agents
1.4. Increasing Burden of Breast Cancer
1.5. Reimbursement Trends
1.6. Artificial Intelligence (AI) Integration and Leveraging Deep Learning Methodology
Chapter 2. Number of Procedures Performed (Breast MRI)
2.1. U.S.
2.2. Canada
2.3. Mexico
2.4. Germany
2.5. UK
2.6. France
2.7. Italy
2.8. Spain
2.9. Denmark
2.10. Norway
2.11. Sweden
2.12. Netherlands
2.13. Rest of Europe
Chapter 3. Cost Per Scan With And/or Without Contrast (USD)
3.1. U.S.
3.2. Canada
3.3. Mexico
3.4. Germany
3.5. UK
3.6. France
3.7. Italy
3.8. Spain
3.9. Denmark
3.10. Norway
3.11. Sweden
3.12. Netherlands
3.13. Rest of Europe
Chapter 4. Company Share Analysis (2024)
4.1. Siemens Healthineers AG
4.2. GE HealthCare
4.3. Koninklijke Philips N.V.
4.4. CANON MEDICAL SYSTEMS CORPORATION
4.5. FUJIFILM Holdings Corporation
4.6. SternMed GmbH
4.7. Aurora Healthcare US Corp
4.8. ClearCut Medical
4.9. Others
Chapter 5. Analyst Perspective
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPA norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.